Here's Why Veracyte (VCYT) is a Strong Momentum Stock - Yahoo …

Sep 4, 2024 · VCYT is a Zacks Rank #1 (Strong Buy) stock, with a Momentum Style Score of A and VGM Score of B. Shares are down 5.3% over the past one week and up 38.8% over the …

CouponFollow Extension

3%
OFF

Here's Why Veracyte (VCYT) Is A Strong Momentum Stock - Yahoo …

3 weeks from now

Sep 4, 2024 · VCYT is a Zacks Rank #1 (Strong Buy) stock, with a Momentum Style Score of A and VGM Score of B. Shares are down 5.3% over the past one week and up 38.8% over the …

yahoo.com

3%
OFF

Why Veracyte (VCYT) Is A Top Momentum Stock For The Long-Term

3 weeks from now

VCYT sits at a Zacks Rank #1 (Strong Buy), holds a Momentum Style Score of A, and has a VGM Score of B. The stock is up 15.3% and up 23.4% over the past one-week and four-week …

yahoo.com

13%
OFF

Here's Why VCYT Stock Could Be A Great Addition To Your

3 weeks from now

Sep 9, 2024 · In the past year, this Zacks Rank #1 (Strong Buy) stock has outperformed both the industry and the S&P 500. Shares have rallied 13% compared with the 12.8% growth of the …

nasdaq.com

55%
OFF

Veracyte Stock: It's Sprinted 55% But Remains An Outlier

3 weeks from now

Dec 12, 2024 · Veracyte (VCYT) is in an envious position for any company — and particularly for a diagnostics player. The medical equipment firm is an outlier in its field, largely because it's …

investors.com

13%
OFF

Here's Why VCYT Stock Could Be A Great Addition To Your …

3 weeks from now

Sep 9, 2024 · In the past year, this Zacks Rank #1 (Strong Buy) stock has outperformed both the industry and the S&P 500. Shares have rallied 13% compared with the 12.8% growth of the …

yahoo.com

55%
OFF

Why Veracyte, With 55% Growth In 2024, Is An Outlier In Cancer

3 weeks from now

Dec 12, 2024 · Veracyte stock has rocketed more than 55% this year. ... Here's why investors can't go wrong with Amazon (NASDAQ: AMZN) and Warren Buffett's Berkshire Hathaway …

yahoo.com

41%
OFF

Why Veracyte Inc’s (VCYT) Stock Is Up 4.41% | AAII - Investor …

3 weeks from now

As of Thursday, September 19, Veracyte Inc’s VCYT share price has surged by 4.41%, which has investors questioning if this is right time to sell. Premium Products ... Basic Membership …

aaii.com

44%
OFF

Veracyte Gains 44% In A Year: What's Driving The Stock?

3 weeks from now

Jan 6, 2025 · Veracyte (VCYT Quick Quote VCYT - Free Report) has seen impressive growth over the past year, with its shares jumping 44%. It has significantly outperformed the industry …

zacks.com

44%
OFF

Veracyte Gains 44% In A Year: What's Driving The Stock? - Yahoo …

3 weeks from now

Jan 6, 2025 · Veracyte VCYT has seen impressive growth over the past year, with its shares jumping 44%. It has significantly outperformed the industry’s 3.9% rise and the S&P 500 …

yahoo.com

$46.12
OFF

Veracyte Stock Soars To 52-Week High, Reaching $46.12

3 weeks from now

4 days ago · Veracyte Inc . (NASDAQ: VCYT), a pioneering genomic diagnostics company with a market capitalization of $3.57 billion, has reached a new 52-week high, with its stock price …

investing.com

$43.67
OFF

Needham & Company LLC Raises Veracyte (NASDAQ:VCYT) Price …

3 weeks from now

5 days ago · Get Our Latest Stock Report on VCYT Veracyte Stock Performance. NASDAQ VCYT opened at $43.67 on Wednesday. Veracyte has a one year low of $18.61 and a one …

marketbeat.com

FAQs about Here's Why Veracyte (VCYT) is a Strong Momentum Stock - Yahoo … Coupon?

Is vcyt a good buy?

VCYT is a Zacks Rank #1 (Strong Buy) stock, with a Momentum Style Score of A and VGM Score of B. Shares are down 5.3% over the past one week and up 38.8% over the past four weeks. VCYT has gained 15.7% in the last one-year period as well. Looking at trading volume, an average of 1,058,447.63 shares exchanged hands over the last 20 trading days. ...

Is Veracyte a good stock to buy in 2024?

Veracyte ’s VCYT growth in the third quarter of 2024 can be attributed to the strong momentum of Afirma. The record volume growth of the Decipher Prostrate test instills optimism. Additionally, strong financial stability bodes well. Meanwhile, headwinds such as macroeconomic issues are worrisome. ...

Should you buy Veracyte vcyt (vcyt)?

Veracyte VCYT has seen impressive growth over the past year, with its shares jumping 44%. It has significantly outperformed the industry’s 3.9% rise and the S&P 500 composite’s 24.4% gain. With a Zacks Rank #1 (Strong Buy) at present, the global diagnostics company is gaining more market shares from the strength of the Afirma solution. ...

What is the benchmark for Veracyte (vcyt)?

Benchmark is S&P 500 Select to analyze similar companies using key performance metrics; select up to 4 stocks. VCYT does not have Company Insights Find the latest Veracyte, Inc. (VCYT) stock quote, history, news and other vital information to help you with your stock trading and investing. ...

What's driving Veracyte vcyt (vcyt) stock?

Veracyte Gains 44% in a Year: What's Driving the Stock? Veracyte VCYT has seen impressive growth over the past year, with its shares jumping 44%. It has significantly outperformed the industry’s 3.9% rise and the S&P 500 composite’s 24.4% gain. ...

Is Veracyte a good buy?

Meanwhile, declining biopharma revenues and macroeconomic issues are worries for Veracyte. In the past year, this Zacks Rank #1 (Strong Buy) stock has outperformed both the industry and the S&P 500. Shares have rallied 13% compared with the 12.8% growth of the industry and a 19.9% rise in the S&P 500 composite. ...